SEC-sourced researchBeta
HBIO
HARVARD BIOSCIENCE INC
Company comparison ↗
Data passport
- CIK
- 0001123494
- Exchange
- Nasdaq
- Business activity
- — · SIC 3826
- Financial inputs
- 6/6
- Filing date
- Sep 22, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 94,135,000.0000 | Mar 13, 2026 |
| December 2025 | 86,550,000.0000 | Mar 13, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 86,550,000.0000 | -56,700,000.0000 | 6,729,000.0000 | 80,071,000.0000 | 66,337,000.0000 | Mar 13, 2026 |
| December 2024 | 94,135,000.0000 | -12,405,000.0000 | 1,440,000.0000 | 126,644,000.0000 | 63,304,000.0000 | Mar 13, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $86.55M | December 2025 | Mar 13, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $94.14M | December 2024 | Mar 13, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$56.7M | December 2025 | Mar 13, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $6.73M | December 2025 | Mar 13, 2026 | 10-K |
| Total assetsAssets | $80.07M | December 2025 | Mar 13, 2026 | 10-K |
| Total liabilitiesLiabilities | $66.34M | December 2025 | Mar 13, 2026 | 10-K |